Table 3.

Relationship of KAP1, TIMP1 and STC2 expression with pathological parameters of tumor

Clinical parameters	KAP1				TIMP1				STC2
	Low	High	χ2	P	Low	High	χ2	P	Low	High	χ2	P
N	13	99			12	100			11	101
Gender			1.52	0.22			0.68	0.41			3.08	0.079
Male	7	70			7	70			5	72
Female	6	29			5	30			6	29
Location			0.184	0.91			1.82	0.40			1.99	0.369
Proximal	1	11			0	12			0	12
Middle	4	32			5	31			5	31
Distal	8	56			7	57			6	58
Size			0.227	0.633			0.156	0.693			0.484	0.487
<5 cm	5	45			6	44			6	44
≥5 cm	8	54			6	56			5	57
Lauren classification			0.56	0.45			0.55	0.46			0.037	0.85
Intestinal	8	50			5	53			6	52
Diffuse	5	49			7	47			5	49
Histology			1.53	0.675			5.376	0.146			2.62	0.454
Papillary adenocarcinoma	0	5			0	5			0	5
Tubular adenocarcinoma	11	69			12	68			10	70
Mucinous adenocarcinoma	1	15			0	16			1	15
Signet-ring cell carcinoma	1	10			0	11			0	11
Histologic differentiation			0.013	0.91			1.97	0.16			0.10	0.75
Well-moderately	4	32			6	30			4	32
Poorly-undifferentiated	9	67			6	70			7	69
TNM Stages			24.31	0.001			36.46	0.001			20.26	0.001
I	7	7			8	6			6	8
II	4	36			2	38			3	37
III	2	37			2	37			1	38
IV	0	19			0	19			1	18
Lymph node metastasis			48.37	0.001			24.15	0.001			41.32	0.001
No	7	1			5	3			6	2
Yes	6	98			7	97			5	99
Distant metastasis			0.898	0.343			2.746	0.098			0.537	0.464
No	12	81			12	81			10	83
Yes	1	18			0	19			1	18